Application 021830

Type: NDA
Sponsor: APIL

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	ASACOL HD	MESALAMINE	TABLET, DELAYED RELEASE;ORAL	800MG	Yes	Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021830-001	ASACOL HD	MESALAMINE	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021830-001	ASACOL HD	800MG	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021830-001	ASACOL HD	800MG	TABLET, DELAYED RELEASE / ORAL	AB	RLD, RS	2008-05-29	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021830-001	ASACOL HD	800MG	TABLET, DELAYED RELEASE / ORAL	AB	RLD, RS	2008-05-29	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021830-001	ASACOL HD	800MG	TABLET, DELAYED RELEASE / ORAL	AB	RLD, RS	2008-05-29	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021830-001	ASACOL HD	800MG	TABLET, DELAYED RELEASE / ORAL	AB	RLD, RS	2008-05-29	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021830-001	ASACOL HD	800MG	TABLET, DELAYED RELEASE / ORAL	AB	RLD, RS	2008-05-29	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021830-001	ASACOL HD	800MG	TABLET, DELAYED RELEASE / ORAL	AB	RLD, RS	2008-05-29	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021830-001	ASACOL HD	800MG	TABLET, DELAYED RELEASE / ORAL	AB	RLD, RS	2008-05-29	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021830-001	ASACOL HD	800MG	TABLET, DELAYED RELEASE / ORAL	AB	RLD, RS	2008-05-29	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021830-001	ASACOL HD	800MG	TABLET, DELAYED RELEASE / ORAL	AB	RLD, RS	2008-05-29	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021830-001	ASACOL HD	800MG	TABLET, DELAYED RELEASE / ORAL	AB	RLD, RS	2008-05-29	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021830-001	ASACOL HD	800MG	TABLET, DELAYED RELEASE / ORAL	AB	RLD, RS	2008-05-29	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021830-001	ASACOL HD	800MG	TABLET, DELAYED RELEASE / ORAL	AB	RLD, RS	2008-05-29	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021830-001	ASACOL HD	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021830-001	ASACOL HD	800MG	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021830-001	ASACOL HD	800MG	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021830-001	ASACOL HD	800MG	TABLET, DELAYED RELEASE / ORAL		RLD	2008-05-29	`f41ea6bd6efb…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-04-08 23:34 UTC	2022-04	N021830-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021830-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021830-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021830-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021830-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021830-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021830-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021830-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021830-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021830-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021830-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021830-001	AB	1	`ea99ee380514…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N021830-001	6893662	2021-11-15	U-141	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021830-001	8580302	2021-11-15		Drug product	2013-11-13	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021830-001	9089492	2021-11-15		Drug product	2015-09-22	`74a2ff9319b5…`
2021-12-28 21:50 UTC	2021-12	N021830-001	6893662	2021-11-15	U-141	Drug product		`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021830-001	8580302	2021-11-15		Drug product	2013-11-13	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021830-001	9089492	2021-11-15		Drug product	2015-09-22	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021830-001	6893662	2021-11-15	U-141	Drug product		`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021830-001	8580302	2021-11-15		Drug product	2013-11-13	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021830-001	9089492	2021-11-15		Drug product	2015-09-22	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021830-001	6893662	2021-11-15	U-141	Drug product		`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021830-001	8580302	2021-11-15		Drug product	2013-11-13	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021830-001	9089492	2021-11-15		Drug product	2015-09-22	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021830-001	6893662	2021-11-15	U-141	Drug product		`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021830-001	8580302	2021-11-15		Drug product	2013-11-13	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021830-001	9089492	2021-11-15		Drug product	2015-09-22	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021830-001	6893662	2021-11-15	U-141	Drug product		`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021830-001	8580302	2021-11-15		Drug product	2013-11-13	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021830-001	9089492	2021-11-15		Drug product	2015-09-22	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021830-001	6893662	2021-11-15	U-141	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021830-001	8580302	2021-11-15		Drug product	2013-11-13	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021830-001	9089492	2021-11-15		Drug product	2015-09-22	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021830-001	6893662	2021-11-15	U-141	Drug product		`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021830-001	8580302	2021-11-15		Drug product	2013-11-13	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021830-001	9089492	2021-11-15		Drug product	2015-09-22	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021830-001	6893662	2021-11-15	U-141	Drug product		`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021830-001	8580302	2021-11-15		Drug product	2013-11-13	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021830-001	9089492	2021-11-15		Drug product	2015-09-22	`ea99ee380514…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 4 · 64 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Mesalamine	MESALAMINE	Padagis Israel Pharmaceuticals Ltd	d50f2c37-5675-49f3-bdd4-3b16d333ed40	2024-08-01	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
Mesalamine	MESALAMINE	Padagis Israel Pharmaceuticals Ltd	a4ddf68d-1502-4242-89aa-c96436bdcbf6	2024-08-01	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
Mesalamine	MESALAMINE	Ascend Laboratories, LLC	43f69db3-81ac-4da4-a61f-fbba6299d9c2	2024-07-03	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
Mesalamine	MESALAMINE	Teva Pharmaceuticals, Inc.	e3b84397-a5a5-40cf-8145-0584103d465f	2024-06-28	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
Mesalamine	MESALAMINE	Bryant Ranch Prepack	06792d20-d7e9-4b66-a4cb-cd0cf1a2db25	2024-06-28	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
Mesalamine	MESALAMINE	Rising Pharma Holdings, Inc.	de981df1-747a-480d-a866-e72332a1544d	2024-06-14	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
MESALAMINE	MESALAMINE	Bryant Ranch Prepack	063ca661-1b5c-4941-a5b9-5dd0fa46b3d0	2024-05-29	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
Mesalamine	MESALAMINE	Amneal Pharmaceuticals LLC	00f77203-3615-47e8-ae25-6e1cf8a2a00a	2024-05-23	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
Mesalamine	MESALAMINE	Bryant Ranch Prepack	c9b1ef9d-1d06-48e7-87d2-7985b99124a6	2024-05-01	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
mesalamine	MESALAMINE	Golden State Medical Supply, Inc.	170657d1-1f32-f036-e063-6294a90a4ed4	2024-04-26	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
MESALAMINE	MESALAMINE	Lannett Company Inc.	29dbe417-15a9-4c4d-846b-81cabda7ac70	2024-02-29	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
Mesalamine	MESALAMINE	Camber Pharmaceuticals, Inc.	efa9d039-ae1f-4cd6-98f2-e87a901dfaeb	2024-02-26	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
Mesalamine	MESALAMINE	Camber Pharmaceuticals, Inc.	04ce2182-2e8c-4598-a269-550cfaddde6c	2024-02-15	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
Mesalamine	MESALAMINE	ANI Pharmaceuticals, Inc.	3cf751f2-a0c9-45d7-8acb-2bc61db0e4ac	2024-02-14	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
Mesalamine	MESALAMINE	Aurobindo Pharma Limited	d6c0fc76-644e-4301-9672-f432061e3d37	2024-01-20	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
MESALAMINE	MESALAMINE	Alembic Pharmaceuticals Inc.	87d3d62d-2dc3-4e6f-be33-cabbca12e8f7	2024-01-09	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
mesalamine	MESALAMINE	Teva Pharmaceuticals USA, Inc.	8d27a608-3ba1-4799-be38-c00fb08ce3ce	2023-12-19	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
Mesalamine Rectal	MESALAMINE	Amring Pharmaceuticals Inc.	87de237c-febb-42ca-b2a4-b444396f8640	2023-12-15	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
Mesalamine	MESALAMINE	Sun Pharmaceutical Industries, Inc.	fd8b02de-7dfa-444d-a1f8-1436b578e0cb	2023-12-01	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE
Mesalamine	MESALAMINE	Mylan Pharmaceuticals Inc.	c8b93ea3-0367-4605-b87f-06c3812ff3b7	2023-11-30	Warnings, Adverse reactions	Name fallback generic name: MESALAMINE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 16 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
0023-5901	Asacol HD	mesalamine	Allergan, Inc.	NDA	Current
0023-5901	Asacol HD	mesalamine	Allergan, Inc.	NDA	Current
0023-5901	Asacol HD	mesalamine	Allergan, Inc.	NDA	Current
0023-5901	Asacol HD	mesalamine	Allergan, Inc.	NDA	Current
0023-5901	Asacol HD	mesalamine	Allergan, Inc.	NDA	Current
0023-5901	Asacol HD	mesalamine	Allergan, Inc.	NDA	Current
0023-5901	Asacol HD	mesalamine	Allergan, Inc.	NDA	Current
0023-5901	Asacol HD	mesalamine	Allergan, Inc.	NDA	Current
0430-0783	ASACOL HD	mesalamine	Allergan, Inc.	NDA	Current
50090-3497	mesalamine	mesalamine	A-S Medication Solutions	NDA AUTHORIZED GENERIC	Current
50090-3497	mesalamine	mesalamine	A-S Medication Solutions	NDA AUTHORIZED GENERIC	Current
50090-3497	mesalamine	mesalamine	A-S Medication Solutions	NDA AUTHORIZED GENERIC	Current
59762-0117	MESALAMINE	MESALAMINE	Greenstone LLC	NDA	Current
60687-347	mesalamine	mesalamine	American Health Packaging	NDA AUTHORIZED GENERIC	Current
68382-484	mesalamine	mesalamine	Zydus Pharmaceuticals (USA) Inc.	NDA AUTHORIZED GENERIC	Current
68382-649	mesalamine	mesalamine	Zydus Pharmaceuticals (USA) Inc.	NDA AUTHORIZED GENERIC	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
72645	SUPPL	2022-11-17
72627	SUPPL	2022-11-17
69194	SUPPL	2021-11-02
69183	SUPPL	2021-11-02
64849	SUPPL	2020-10-06
64800	SUPPL	2020-10-02
64107	SUPPL	2020-07-28
53769	SUPPL	2018-04-23
53742	SUPPL	2018-04-19
49139	SUPPL	2017-07-28
49125	SUPPL	2017-07-28
16431	SUPPL	2016-05-06
6275	SUPPL	2016-05-06
37734	SUPPL	2013-10-22
28674	SUPPL	2013-10-21
37733	SUPPL	2012-05-14
28673	SUPPL	2010-05-28
21837	ORIG	2009-05-15
37732	SUPPL	2009-04-28
28672	SUPPL	2009-04-27
24220	ORIG	2008-07-17
37731	ORIG	2008-06-12
28671	ORIG	2008-06-03
51336	SUPPL	1900-01-01
51335	SUPPL	1900-01-01
51334	SUPPL	1900-01-01